The company has explored several options, including interest for a private
placement, but is still in need of new capital to fund the company's operations
and liabilities. It will continue its efforts to solve the short- and long-term
liquidity needs, which may involve a wider capital raising, divestment of assets
or strategy changes. The company will update the market once it has specific
news.

For further information, please contact:
Geir Almås, Executive Chairman of SoftOx Solutions AS 
Christian Harstad, Interim CEO of SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and
clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of
reducing the spread of infection and emergence of antimicrobial resistance. For
more information on SoftOx, visit www.soft-ox.com